AEON Biopharma's total assets for Q3 2024 were $4.00M, an increase of 32.06% from the previous quarter. AEON total liabilities were $36.09M for the fiscal quarter, a -82.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.